Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

142.62 +2.89 (+2.07%)
Official Closing Price Updated: 4:15 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 691,700
Open 143.28
Bid (Size) 141.50 (100)
Ask (Size) 150.00 (500)
Prev. Close 139.73
Today's Range 141.13 - 147.71
52wk Range 55.17 - 147.71
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
From GeneDx
Via Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Emerges as a Premier Growth and Momentum Stock
GeneDx (WGS) stock aligns with growth & momentum strategies, showing a powerful uptrend backed by explosive earnings growth and strong technical health. 
Via Chartmill

Performance

YTD
+79.1%
+79.1%
1 Month
+18.0%
+18.0%
3 Month
+29.0%
+29.0%
6 Month
+141.7%
+141.7%
1 Year
+94.3%
+94.3%

More News

Read More
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
What Does the Market Think About GeneDx Holdings Corp?
Via Benzinga
Earnings Scheduled For October 28, 2025
Via Benzinga
GeneDx Hldgs's Earnings: A Preview
Via Benzinga
GeneDx (WGS) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher
Via Chartmill
Topics Earnings
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
From GeneDx
Via Business Wire
4 Analysts Assess GeneDx Holdings: What You Need To Know
Via Benzinga
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
From GeneDx
Via Business Wire
This WillScot Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
From GeneDx
Via Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Presents a High-Growth Momentum and Technical Breakout Case
Via Chartmill
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
From GeneDx
Via Business Wire
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
From GeneDx
Via Business Wire
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
From GeneDx
Via Business Wire
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
From GeneDx
Via Business Wire
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
From GeneDx
Via Business Wire
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
From GeneDx
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
From GeneDx
Via Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Positive Technical Setup
Via Chartmill

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 142.62
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 11/10/25 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.